CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diepersloot, R. J. A.
Right arrow Articles by Gleaves, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diepersloot, R. J. A.
Right arrow Articles by Gleaves, C. A.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, November 2000, p. 865-866, Vol. 7, No. 6
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Comparison of a Chemiluminescent Immunoassay with Two Microparticle Enzyme Immunoassays for Detection of Hepatitis B Virus Surface Antigen

Robert J. A. Diepersloot,1,* Yvonne van Zantvliet-van Oostrom,1 and Curt A. Gleaves2

Laboratory for Medical Microbiology, Diakonessen Hospital, Utrecht, The Netherlands,1 and Infectious Disease and Molecular Diagnostics, Providence Portland Medical Center, Portland, Oregon2

Received 11 February 2000/Returned for modification 31 May 2000/Accepted 1 August 2000

A comparative evaluation of the following commercial immunoassays for the detection of hepatitis B virus surface antigen (HBsAg) was performed: the Abbott AxSYM, Abbott IMx, and DPC IMMULITE assays. The specificity was 100% for all assays. Twelve samples were identified and were confirmed to be positive for HBsAg by all three methods. One additional sample was identified as reactive and was confirmed to be positive by the Abbott AxSYM assay only. Prior to confirmation testing the DPC IMMULITE assay produced significantly fewer false-positive results than the Abbott AxSYM assay (P < 0.05).

* Corresponding author. Mailing address: Laboratory for Medical Microbiology, Diakonessen Hospital, 1, Bosboomstraat, 3582 KE Utrecht, The Netherlands. Phone: 31 30 256 65 66. Fax: 31 30 256 66 95. E-mail: rdiepersloot{at}diakhuis.nl

Clinical and Diagnostic Laboratory Immunology, November 2000, p. 865-866, Vol. 7, No. 6
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2000 by the American Society for Microbiology. All rights reserved.